Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoresection vs TUR + Mitomycin C in Bladder Cancer
NCT00042887Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2002
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of mitomycin c in bladder cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started May 2002; status: terminated.
02
Drugs
mitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00042887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042887.